COSMOS Pharmaceutical Corporation (TYO:3349)

Market Cap	528.41B -6.4%
Revenue (ttm)	1.04T +4.8%
Net Income	31.20B +14.3%
EPS	393.63 +14.3%
Shares Out	79.26M
PE Ratio	16.94
Forward PE	16.19
Dividend	75.00 (1.12%)
Ex-Dividend Date	May 28, 2026

Volume	298,200
Average Volume	423,460
Open	6,624.00
Previous Close	6,568.00
Day's Range	6,615.00 - 6,709.00
52-Week Range	6,355.00 - 10,045.00
Beta	0.20
RSI	44.19
Earnings Date	Apr 13, 2026

About COSMOS Pharmaceutical

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1983
• Employees: 5,709
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3349

Financial Performance

In fiscal year 2025, COSMOS Pharmaceutical's revenue was 1.01 trillion, an increase of 4.81% compared to the previous year's 964.99 billion. Earnings were 30.98 billion, an increase of 26.68%.